Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/25 16:47 | 6/11/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | 2 | S.d | -778 | 47.16 | 0 | -17 | -100 | 0 | D | |||||||||||||||
6/3/25 18:30 | 6/3/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | 1 | S.d | -245 | 49.04 | 0 | -5 | -100 | 0 | D | |||||||||||||||
6/3/25 18:30 | 6/3/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | 1 | S.d | -1,470 | 49.00 | 0 | -30 | 660 | D | |||||||||||||||
6/3/25 18:30 | 6/3/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Albers Jeffrey W. | MA | D | 1 | S.d | -311 | 49.00 | 0 | -6 | -100 | 0 | D | |||||||||||||||
5/23/25 16:30 | 5/23/25 | KYMR | Health | BioPrd | Biological Products, (No Diag | Chadwick Jeremy G | MA | O | COO | 1 | S | -75 | 29.30 | 0 | -3 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |